vancomycin PK in older adults
Indication: Serious Gram-positive infections in adults aged 65 years or older
Interactive vancomycin population PK simulator for older adults exploring IV dose, infusion duration, dosing interval, creatinine clearance, AUC24, peak, and trough exposure.
Drug Overview
Clinical Context
- Molecular Target
- D-Ala-D-Ala termini of bacterial cell-wall precursors
- Drug Class
- Glycopeptide antibiotic
- Therapeutic Area
- Infectious diseases / Geriatrics
- Indication
- Serious Gram-positive infections in adults aged 65 years or older
- Route of Administration
- Intravenous
Model Information
- Model Type
- One-compartment population PK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
Pharmacokinetic Parameters
Additional Parameters
| Parameter | Value |
|---|---|
| V L | 83.3 |
| CL equation | 3.02*(CrCL/65.24)^0.856 |
| IIV V CV pct | 48.8 |
| IIV CL CV pct | 30.8 |
| additive error mg L | 1.92 |
| proportional error pct | 20.8 |
Parameters sourced from published population pharmacokinetic models. Values represent typical population estimates; individual patient parameters may vary.
About This Simulator
This interactive pharmacokinetic simulator for vancomycin allows you to explore concentration-time profiles under different dosing scenarios. The underlying One-compartment population PK model characterizes the pharmacokinetics of this glycopeptide antibiotic following intravenous administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the vancomycin PK simulator?
This is a free, interactive pharmacokinetic simulator for vancomycin used in Serious Gram-positive infections in adults aged 65 years or older. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does vancomycin belong to?
vancomycin is classified as a Glycopeptide antibiotic that targets D-Ala-D-Ala termini of bacterial cell-wall precursors. It is used in the Infectious diseases / Geriatrics therapeutic area.
What route of administration does this model simulate?
This simulator models Intravenous administration of vancomycin. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a One-compartment population PK model. This model characterizes the time-course of drug concentrations following dosing.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Gentamicin in older adults
Gram-negative bacterial infections in older adults
Population Vancomycin Model
Suspected or confirmed Staphylococcus aureus infections in extremely obese adults
Vancomycin Hemodialysis PopPK Simulator
Serious gram-positive infections requiring IV vancomycin
Ready to Simulate?
Launch the vancomycin simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community